Top Medical News

Epilepsy Foundation and Eisai Partner to Develop EDEN Patient Platform

May 08, 2021

By Matt Hoffman

The Epilepsy Digital Experience Navigator, or EDEN, platform, is being developed in tandem with Embleema, with an aim of improving data use and collection for individuals with epilepsy.

TNFαi Inhibitors and CNS Demyelination

May 08, 2021

By Victoria Johnson

Spencer Hutto, MD, a fellow of autoimmune neurology at Massachusetts General Hospital, discussed his team’s investigation into demyelinating events after the use of TNFαi inhibitors.

NeurologyLive Friday 5 — May 7, 2021

May 07, 2021

By NeurologyLive Staff

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending May 7, 2021.

Solriamfetol and the Impact of Residual Excessive Daytime Sleepiness

May 07, 2021

By Marco Meglio

Paula K. Schweitzer, PhD, discussed her findings on the safety and efficacy of solriamfetol in patients receiving OSA therapy and the need for more research on residual excessive daytime sleepiness.

Exposure to Sleep Medicine Education Is Low in Parent ACGME Training Programs

May 07, 2021

By Marco Meglio

Didactic lectures were the most commonly used teaching format by all specialties, with pulmonary and critical care medicine and neurology reporting the highest hours of attendance.

Featured

Episode 36: Zavegepant and the Gepant Class for Migraine Care

"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Elyse Stock, MD, and Thomas Shoivitz, MD.

NeuroVoices: Vineet Punia, MD, MS, on Responsive Neurostimulation in Older Adults

The neurologist from Cleveland Clinic discussed his study presented at AAN 2021 involving the use of responsive neurostimulation in older adults with drug-resistant focal epilepsy and further expanding research in this space.

Coverage of the 2021 American Academy of Neurology Annual Meeting

All the latest news and updates that the Annual Meeting offers on scientific breakthroughs and cutting-edge therapeutics in neurology, straight from the virtual conference floor.

Disease Spotlight: Migraine

Explore NeurologyLive's coverage of the news and updates on the clinical care of patients with migraine, including interviews with experts in the field and the latest FDA actions.

Disease Spotlight: Multiple Sclerosis

Explore NeurologyLive's coverage of the news and updates on the clinical care of patients with multiple sclerosis, including interviews with experts in the field and the latest FDA actions.

Latest Videos

The Patient-Centered Visit & Shared Decision Making in the Management of Migraine

Strategies in Treating Relapsing-Remitting Multiple Sclerosis

Treating Epilepsy: Key Takeaways From AES 2020

Dosage Finding for IMU-838 in Relapsing MS: Robert Fox, MD

VY-HTT01 IND Accepted, SUDEP Associated With Abnormal Cardiac Response, Humoral Response in MS DMTs Identified

The Issue of Practice Effects on MS Performance Tests: Stephen Rao, PhD, ABPP-Cn

Optimizing Treatment in Acute Migraine: Stephanie J. Nahas, MD

The Importance of ALS Awareness Month: Matthew B. Harms, MD

Remote Screening for Cognitive Impairment: Richard Gershon, PhD

Gaps in Access to Device-Aided Therapies for Parkinson Disease: Hubert Fernandez, MD

Diagnosis Through Teleneurology: Jason Poon, MD

Data-Driven Categorization of Patients With Multiple Sclerosis: Daniel Ontaneda, MD, PhD

Advantages of Atogepant in Ever-Growing CGRP Market: Lawrence Severt, MD, PhD

Most Recent

GammaCore nVNS Deemed Effective for Acute Treatment, Prevention of Cluster Headache

May 06, 2021

Article

A recent review outlined the clinical features, pathophysiology, and treatments for cluster headache, finding noninvasive vagus nerve stimulation to be effective in various ways.

Lecanemab (BAN2401) Reduces Amyloid in Alzheimer Disease Across 18-Month Study

May 06, 2021

Article

Findings on multiple cognitive end points and biomarkers support lecanemab’s therapeutic concept for the targeting of specific oligomeric species in the process of pathophysiological amyloid generation in Alzheimer disease.

Nipocalimab in Myasthenia Gravis and the Remaining Needs for Patients

May 06, 2021

Article

Jeffrey Guptill, MD, MS, MHS, associate professor of neurology at neurologist at Duke University, detailed early positive results for nipocalimab in myasthenia gravis and the urgency to provide more treatment options for patients.

SRP-5051 Builds Momentum in Duchenne Muscular Dystrophy With Positive Phase 2 Data

May 05, 2021

Article

Results showed that SRP-5051 30 mg/kg is likely to deliver greater than 10% dystrophin over time with monthly dosing in Duchenne muscular dystrophy.

FAST Grant Enables Creation of Angelman Syndrome Hotline

May 05, 2021

Article

Recent Foundation for Angelman Syndrome Therapeutics grants funded the hotline as well as work to develop cell line models for rarer genotypes of AS.

FDA Clears IND Application for Huntington Disease Therapy VY-HTT01

May 05, 2021

Article

In preclinical data, VY-HTT01 showed a robust and durable reduction of huntingtin mRNA and protein while distributed across core areas of Huntington disease pathology.

NeuroVoices: Vineet Punia, MD, MS, on Responsive Neurostimulation in Older Adults

May 05, 2021

Article

Abnormal Cardiac Autonomic Response Observed Prior to SUDEP

May 04, 2021

Article

Researchers found that patients with epilepsy that later died from SUDEP had an abnormal cardiac response after hyperventilation.

Understanding Fenfluramine’s Impact on Executive Function in Lennox-Gastaut Syndrome

May 04, 2021

Article

Kim Bishop, PhD, and Arnold Gammaitoni, PharmD, discussed the ways fenfluramine impacts not only seizure frequency, but executive function in individuals with Lennox-Gastaut syndrome.